Cargando…
Value of CD44 immunostaining (IHC) as a surrogate in the differentiation of MYC-positive Burkitt lymphoma (BL) and Burkitt lymphoma-like (BLL) from MYC-negative Diffuse Large B-Cell Lymphoma (DLBCL) in a resource constrained clinical setting
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4261845/ http://dx.doi.org/10.1186/1750-9378-4-S2-P6 |
_version_ | 1782348342180708352 |
---|---|
author | Ayers, LW Ogwang, M Zhou, W Mbulaiteye, SM Bhatia, K |
author_facet | Ayers, LW Ogwang, M Zhou, W Mbulaiteye, SM Bhatia, K |
author_sort | Ayers, LW |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-4261845 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2009 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-42618452014-12-10 Value of CD44 immunostaining (IHC) as a surrogate in the differentiation of MYC-positive Burkitt lymphoma (BL) and Burkitt lymphoma-like (BLL) from MYC-negative Diffuse Large B-Cell Lymphoma (DLBCL) in a resource constrained clinical setting Ayers, LW Ogwang, M Zhou, W Mbulaiteye, SM Bhatia, K Infect Agent Cancer Poster Presentation BioMed Central 2009-06-17 /pmc/articles/PMC4261845/ http://dx.doi.org/10.1186/1750-9378-4-S2-P6 Text en Copyright © 2009 Ayers et al; licensee BioMed Central Ltd. |
spellingShingle | Poster Presentation Ayers, LW Ogwang, M Zhou, W Mbulaiteye, SM Bhatia, K Value of CD44 immunostaining (IHC) as a surrogate in the differentiation of MYC-positive Burkitt lymphoma (BL) and Burkitt lymphoma-like (BLL) from MYC-negative Diffuse Large B-Cell Lymphoma (DLBCL) in a resource constrained clinical setting |
title | Value of CD44 immunostaining (IHC) as a surrogate in the differentiation of MYC-positive Burkitt lymphoma (BL) and Burkitt lymphoma-like (BLL) from MYC-negative Diffuse Large B-Cell Lymphoma (DLBCL) in a resource constrained clinical setting |
title_full | Value of CD44 immunostaining (IHC) as a surrogate in the differentiation of MYC-positive Burkitt lymphoma (BL) and Burkitt lymphoma-like (BLL) from MYC-negative Diffuse Large B-Cell Lymphoma (DLBCL) in a resource constrained clinical setting |
title_fullStr | Value of CD44 immunostaining (IHC) as a surrogate in the differentiation of MYC-positive Burkitt lymphoma (BL) and Burkitt lymphoma-like (BLL) from MYC-negative Diffuse Large B-Cell Lymphoma (DLBCL) in a resource constrained clinical setting |
title_full_unstemmed | Value of CD44 immunostaining (IHC) as a surrogate in the differentiation of MYC-positive Burkitt lymphoma (BL) and Burkitt lymphoma-like (BLL) from MYC-negative Diffuse Large B-Cell Lymphoma (DLBCL) in a resource constrained clinical setting |
title_short | Value of CD44 immunostaining (IHC) as a surrogate in the differentiation of MYC-positive Burkitt lymphoma (BL) and Burkitt lymphoma-like (BLL) from MYC-negative Diffuse Large B-Cell Lymphoma (DLBCL) in a resource constrained clinical setting |
title_sort | value of cd44 immunostaining (ihc) as a surrogate in the differentiation of myc-positive burkitt lymphoma (bl) and burkitt lymphoma-like (bll) from myc-negative diffuse large b-cell lymphoma (dlbcl) in a resource constrained clinical setting |
topic | Poster Presentation |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4261845/ http://dx.doi.org/10.1186/1750-9378-4-S2-P6 |
work_keys_str_mv | AT ayerslw valueofcd44immunostainingihcasasurrogateinthedifferentiationofmycpositiveburkittlymphomablandburkittlymphomalikebllfrommycnegativediffuselargebcelllymphomadlbclinaresourceconstrainedclinicalsetting AT ogwangm valueofcd44immunostainingihcasasurrogateinthedifferentiationofmycpositiveburkittlymphomablandburkittlymphomalikebllfrommycnegativediffuselargebcelllymphomadlbclinaresourceconstrainedclinicalsetting AT zhouw valueofcd44immunostainingihcasasurrogateinthedifferentiationofmycpositiveburkittlymphomablandburkittlymphomalikebllfrommycnegativediffuselargebcelllymphomadlbclinaresourceconstrainedclinicalsetting AT mbulaiteyesm valueofcd44immunostainingihcasasurrogateinthedifferentiationofmycpositiveburkittlymphomablandburkittlymphomalikebllfrommycnegativediffuselargebcelllymphomadlbclinaresourceconstrainedclinicalsetting AT bhatiak valueofcd44immunostainingihcasasurrogateinthedifferentiationofmycpositiveburkittlymphomablandburkittlymphomalikebllfrommycnegativediffuselargebcelllymphomadlbclinaresourceconstrainedclinicalsetting |